Clinical characteristics associated with mortality of patients with anaerobic bacteremia. 2016

Takumi Umemura, and Yukihiro Hamada, and Yuka Yamagishi, and Hiroyuki Suematsu, and Hiroshige Mikamo
Department of Clinical Infectious Diseases, Aichi Medical University Graduate School of Medicine, Japan; Department of Pharmacy, Tosei General Hospital, Japan.

The presence of anaerobes in the blood stream is known to be associated with a higher rate of mortality. However, few prognostic risk factor analyses examining whether a patient's background characteristics are associated with the prognosis have been reported. We performed a retrospective case-controlled study to assess the prognostic factors associated with death from anaerobic bacteremia. Seventy-four patients with anaerobic bacteremia were treated between January 2005 and December 2014 at Aichi Medical University Hospital. The clinical information included drug susceptibility was used for analysis of prognostic factors for 30-day mortality. Multivariate logistic analyses revealed an association between the 30-day mortality rate and malignancy (OR: 3.64, 95% CI: 1.08-12.31) and clindamycin resistance (OR: 7.93, 95% CI: 2.33-27.94). The result of Kaplan-Meier analysis of mortality showed that the 30-day survival rate was 83% in clindamycin susceptible and 38.1% in clindamycin resistant anaerobes causing bacteremia. The result of log-rank test also showed that susceptibility to clindamycin affected mortality (P < 0.001). Our results indicated that malignancy and clindamycin susceptibility could be used to identify subgroups of patients with anaerobic bacteremia with a higher risk of 30-day mortality. The results of this study are important for the early and appropriate management of patients with anaerobic bacteremia.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002981 Clindamycin An antibacterial agent that is a semisynthetic analog of LINCOMYCIN. 7-Chloro-7-deoxylincomycin,Chlolincocin,Chlorlincocin,Cleocin,Clindamycin Hydrochloride,Clindamycin Monohydrochloride,Clindamycin Monohydrochloride, Monohydrate,Dalacin C,7 Chloro 7 deoxylincomycin,Hydrochloride, Clindamycin,Monohydrate Clindamycin Monohydrochloride,Monohydrochloride, Clindamycin,Monohydrochloride, Monohydrate Clindamycin
D003013 Clostridium A genus of motile or nonmotile gram-positive bacteria of the family Clostridiaceae. Many species have been identified with some being pathogenic. They occur in water, soil, and in the intestinal tract of humans and lower animals.
D003015 Clostridium Infections Infections with bacteria of the genus CLOSTRIDIUM and closely related CLOSTRIDIOIDES species. Clostridioides Infections,Clostridioides difficile Infection,Clostridioides perfringens Food Poisoning,Clostridioides perfringens Infections,Clostridioides sordellii Infection,Clostridium difficile Infections,Clostridium sordellii Infections,Clostridium difficile Infection,Clostridium perfringens Food Poisoning,Clostridium perfringens Infections,Clostridium sordellii Infection,Infections, Clostridium,Clostridioides Infection,Clostridioides perfringens Infection,Clostridium Infection,Clostridium perfringens Infection,Infection, Clostridioides difficile,Infection, Clostridioides sordellii,Infection, Clostridium,Infection, Clostridium difficile,Infection, Clostridium sordellii
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Takumi Umemura, and Yukihiro Hamada, and Yuka Yamagishi, and Hiroyuki Suematsu, and Hiroshige Mikamo
April 2004, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Takumi Umemura, and Yukihiro Hamada, and Yuka Yamagishi, and Hiroyuki Suematsu, and Hiroshige Mikamo
January 1992, The American journal of medicine,
Takumi Umemura, and Yukihiro Hamada, and Yuka Yamagishi, and Hiroyuki Suematsu, and Hiroshige Mikamo
August 2009, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi,
Takumi Umemura, and Yukihiro Hamada, and Yuka Yamagishi, and Hiroyuki Suematsu, and Hiroshige Mikamo
December 2007, Enfermedades infecciosas y microbiologia clinica,
Takumi Umemura, and Yukihiro Hamada, and Yuka Yamagishi, and Hiroyuki Suematsu, and Hiroshige Mikamo
May 2022, Journal of clinical medicine,
Takumi Umemura, and Yukihiro Hamada, and Yuka Yamagishi, and Hiroyuki Suematsu, and Hiroshige Mikamo
February 1981, American journal of clinical pathology,
Takumi Umemura, and Yukihiro Hamada, and Yuka Yamagishi, and Hiroyuki Suematsu, and Hiroshige Mikamo
June 1985, Surgery, gynecology & obstetrics,
Takumi Umemura, and Yukihiro Hamada, and Yuka Yamagishi, and Hiroyuki Suematsu, and Hiroshige Mikamo
December 2023, Anaerobe,
Takumi Umemura, and Yukihiro Hamada, and Yuka Yamagishi, and Hiroyuki Suematsu, and Hiroshige Mikamo
January 2012, Internal medicine (Tokyo, Japan),
Takumi Umemura, and Yukihiro Hamada, and Yuka Yamagishi, and Hiroyuki Suematsu, and Hiroshige Mikamo
June 2016, Infection & chemotherapy,
Copied contents to your clipboard!